Please assess the completion status of the following clinical trial:

Trial Title: Effects of Mutations of the Glycine Gene Associated With Hyperekplexia on Central Pain Processing

Study Design Characteristics:
- Allocation: None
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Hyperekplexia~* GLRA1~* GLRB~* SCLA5~* GPHN~* Gephyrin~* ARHGEF9~Exclusion Criteria~* Age below 7 years~* Pregnancy~* Breast feeding~* Ongoing medication~* Cognitive impairment

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): In the setting of comparing patients with a genetic mutation and healthy volunteers blinding of the PI would demand a substantial increase in co-workers (i.e. recruitment, selection of age-and sex matched volunteers), reason why no blinding was chosen.~Affected patients will be compared to age and sex matched volunteers, recruited after completion of testing 23 hyperekplexia patients.

Based on this trial design, predict the completion outcome and termination type (if applicable).